CN Stock MarketDetailed Quotes

300791 Sirio Pharma

Watchlist
  • 41.69
  • -0.37-0.88%
Market Closed May 10 15:00 CST
7.57BMarket Cap24.06P/E (TTM)

Sirio Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
35.51%951.5M
42.87%3.58B
39.96%2.5B
39.00%1.54B
66.69%702.16M
5.84%2.51B
2.31%1.79B
-4.60%1.11B
-17.01%421.25M
14.62%2.37B
Operating revenue
35.51%951.5M
42.87%3.58B
39.96%2.5B
39.00%1.54B
66.69%702.16M
5.84%2.51B
2.31%1.79B
-4.60%1.11B
-17.01%421.25M
14.62%2.37B
Other operating revenue
----
-1.94%13.91M
----
8.96%3.75M
----
-62.66%14.19M
----
11.54%3.44M
----
1.56%38.01M
Total operating cost
28.65%879.05M
46.34%3.31B
43.91%2.31B
44.60%1.44B
63.13%683.27M
7.19%2.26B
4.44%1.6B
-0.63%998.97M
-5.74%418.84M
17.94%2.11B
Operating cost
29.99%660.17M
44.76%2.5B
41.85%1.75B
44.14%1.09B
67.65%507.88M
8.27%1.73B
6.16%1.23B
-0.52%756.11M
-7.51%302.94M
14.41%1.59B
Operating tax surcharges
51.47%6.94M
50.90%22.41M
45.57%15.96M
30.74%9.45M
52.77%4.58M
3.17%14.85M
4.09%10.96M
2.93%7.23M
-2.81%3M
12.34%14.4M
Operating expense
39.75%73.09M
113.33%277.61M
113.85%185.35M
127.55%114.35M
132.01%52.3M
-12.58%130.13M
-18.06%86.67M
-28.10%50.25M
-34.40%22.54M
21.69%148.86M
Administration expense
10.74%91.97M
15.24%350.83M
14.23%245.46M
16.08%165.41M
35.91%83.05M
24.45%304.44M
25.12%214.88M
26.42%142.49M
9.71%61.11M
26.11%244.64M
Financial expense
31.80%16.08M
629.63%52.31M
1,124.70%35.32M
480.90%18.96M
15.93%12.2M
-72.79%7.17M
-113.32%-3.45M
-78.63%3.26M
72.06%10.52M
725.31%26.35M
-Interest expense (Financial expense)
53.90%17.8M
48.58%61.86M
265.74%50M
263.41%32.02M
143.46%11.56M
209.88%41.63M
-55.40%13.67M
-47.03%8.81M
2,843.40%4.75M
646.09%13.43M
-Interest Income (Financial expense)
21.93%-1.4M
39.40%-7.02M
-1.89%-8.76M
26.42%-3.26M
26.33%-1.79M
-65.57%-11.58M
33.25%-8.6M
41.09%-4.43M
-282.16%-2.43M
-67.65%-6.99M
Research and development
36.99%30.79M
36.89%110.49M
24.24%75.47M
17.35%46.5M
20.05%22.48M
-2.97%80.72M
2.53%60.75M
-1.91%39.62M
6.74%18.72M
28.56%83.19M
Credit Impairment Loss
-95.91%69.47K
-29.64%-5.18M
-128.20%-451.13K
433.55%2.42M
-38.93%1.7M
-314.19%-3.99M
260.80%1.6M
45.66%-725.99K
747.87%2.78M
72.80%-964.14K
Asset Impairment Loss
-242.54%-1.36M
108.15%405.38K
62.37%-828.29K
21.30%-2.24M
51.42%-397.78K
-142.00%-4.98M
-207.12%-2.2M
-4,402.67%-2.85M
-262.05%-818.76K
20.00%-2.06M
Adjustment items of total operating cost
----
----
----
----
--780.11K
----
----
----
----
----
Other net revenue
-92.47%457.3K
-43.99%11.58M
-98.05%471.35K
-85.19%2.62M
-60.39%6.08M
-35.48%20.67M
4.17%24.17M
28.27%17.67M
84.80%15.34M
-17.53%32.03M
Fair value change income
242.62%2.74M
-3,421.47%-57.67M
-2,212.21%-12.82M
-42,632.57%-6.98M
-59.87%800.27K
-56.51%-1.64M
241.97%606.77K
98.65%-16.33K
123.26%1.99M
-126.49%-1.05M
Invest income
-589.44%-4.87M
-90.51%2.22M
-66.78%3.98M
-78.26%2.69M
-76.08%994.85K
-7.13%23.39M
-20.63%11.99M
15.78%12.37M
31.20%4.16M
55.86%25.19M
Asset deal income
--131.96K
-76.37%34.01K
59.13%22.9K
261.50%47.11K
----
-5.92%143.93K
101.76%14.39K
1,547.71%13.03K
189.70%13.03K
2,301.50%152.99K
Other revenue
25.72%3.75M
827.75%71.77M
-13.14%10.56M
-24.80%6.68M
-58.67%2.98M
-28.06%7.74M
10.02%12.16M
55.81%8.88M
72.64%7.21M
-56.72%10.75M
Operating profit
192.06%72.91M
6.40%282.02M
-5.99%197.56M
-20.88%102.94M
40.68%24.97M
-8.54%265.06M
-11.35%210.15M
-25.01%130.1M
-75.19%17.75M
-8.17%289.81M
Add:Non operating Income
371.52%1.15M
60.77%1.36M
55.16%1.29M
-57.05%536.65K
-78.61%244.59K
-58.20%848.83K
-8.74%828.46K
54.80%1.25M
156.03%1.14M
119.60%2.03M
Less:Non operating expense
1,557.87%4.74M
-29.57%10.13M
-75.43%2.11M
-88.78%727.87K
-73.64%286.1K
31.45%14.39M
3.33%8.59M
162.33%6.49M
-48.62%1.09M
139.33%10.94M
Total profit
178.15%69.32M
8.64%273.26M
-2.79%196.73M
-17.71%102.75M
39.99%24.92M
-10.46%251.52M
-11.87%202.39M
-27.33%124.86M
-74.51%17.8M
-9.96%280.9M
Less:Income tax cost
150.64%15.45M
-15.97%32.97M
41.23%37.03M
52.58%22.8M
94.75%6.17M
-20.04%39.23M
-10.40%26.22M
-42.62%14.95M
-74.65%3.17M
-10.13%49.07M
Net profit
187.19%53.87M
13.19%240.29M
-9.35%159.7M
-27.27%79.94M
28.14%18.76M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
-74.48%14.64M
-9.92%231.83M
Net profit from continuing operation
187.19%53.87M
13.19%240.29M
-9.35%159.7M
-27.27%79.94M
28.14%18.76M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
-74.48%14.64M
-9.92%231.83M
Less:Minority Profit
13.94%-9.16M
---40.75M
---25.45M
---21.24M
---10.64M
----
----
----
----
----
Net profit of parent company owners
114.39%63.03M
32.39%281.04M
5.10%185.15M
-7.94%101.19M
100.84%29.4M
-8.43%212.29M
-12.08%176.17M
-24.60%109.92M
-74.48%14.64M
-9.92%231.83M
Earning per share
Basic earning per share
113.14%0.3472
32.15%1.5585
5.10%1.03
-8.20%0.56
100.62%0.1629
-8.42%1.1793
-11.71%0.98
-24.69%0.61
-74.63%0.0812
-9.95%1.2877
Diluted earning per share
81.97%0.3472
33.47%1.5585
8.42%1.03
-5.08%0.56
102.55%0.1908
-4.15%1.1677
-15.18%0.95
-27.16%0.59
-70.56%0.0942
-14.21%1.2182
Other composite income
79.41%-26.69M
42.61%19.67M
6,584.17%73.63M
2,729.92%76.35M
-25,837.28%-129.63M
157.35%13.79M
91.48%-1.14M
168.40%2.7M
87.33%-499.8K
-592.98%-24.05M
Other composite income of parent company owners
79.32%-21.14M
3.24%14.24M
6,307.64%70.49M
2,663.68%74.56M
-20,349.46%-102.21M
157.35%13.79M
91.48%-1.14M
168.40%2.7M
87.33%-499.8K
-592.98%-24.05M
Other composite income of minority owners
79.74%-5.56M
--5.43M
--3.14M
--1.79M
---27.43M
----
----
----
----
----
Total composite income
124.51%27.18M
14.99%259.96M
33.30%233.33M
38.79%156.29M
-884.19%-110.88M
8.80%226.08M
-6.43%175.03M
-20.60%112.61M
-73.53%14.14M
-18.16%207.79M
Total composite income of parent company owners
157.54%41.89M
30.61%295.28M
46.05%255.63M
56.06%175.75M
-614.94%-72.81M
8.80%226.08M
-6.43%175.03M
-20.60%112.61M
-73.53%14.14M
-18.16%207.79M
Total composite income of minority owners
61.35%-14.72M
---35.32M
---22.31M
---19.45M
---38.07M
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 35.51%951.5M42.87%3.58B39.96%2.5B39.00%1.54B66.69%702.16M5.84%2.51B2.31%1.79B-4.60%1.11B-17.01%421.25M14.62%2.37B
Operating revenue 35.51%951.5M42.87%3.58B39.96%2.5B39.00%1.54B66.69%702.16M5.84%2.51B2.31%1.79B-4.60%1.11B-17.01%421.25M14.62%2.37B
Other operating revenue -----1.94%13.91M----8.96%3.75M-----62.66%14.19M----11.54%3.44M----1.56%38.01M
Total operating cost 28.65%879.05M46.34%3.31B43.91%2.31B44.60%1.44B63.13%683.27M7.19%2.26B4.44%1.6B-0.63%998.97M-5.74%418.84M17.94%2.11B
Operating cost 29.99%660.17M44.76%2.5B41.85%1.75B44.14%1.09B67.65%507.88M8.27%1.73B6.16%1.23B-0.52%756.11M-7.51%302.94M14.41%1.59B
Operating tax surcharges 51.47%6.94M50.90%22.41M45.57%15.96M30.74%9.45M52.77%4.58M3.17%14.85M4.09%10.96M2.93%7.23M-2.81%3M12.34%14.4M
Operating expense 39.75%73.09M113.33%277.61M113.85%185.35M127.55%114.35M132.01%52.3M-12.58%130.13M-18.06%86.67M-28.10%50.25M-34.40%22.54M21.69%148.86M
Administration expense 10.74%91.97M15.24%350.83M14.23%245.46M16.08%165.41M35.91%83.05M24.45%304.44M25.12%214.88M26.42%142.49M9.71%61.11M26.11%244.64M
Financial expense 31.80%16.08M629.63%52.31M1,124.70%35.32M480.90%18.96M15.93%12.2M-72.79%7.17M-113.32%-3.45M-78.63%3.26M72.06%10.52M725.31%26.35M
-Interest expense (Financial expense) 53.90%17.8M48.58%61.86M265.74%50M263.41%32.02M143.46%11.56M209.88%41.63M-55.40%13.67M-47.03%8.81M2,843.40%4.75M646.09%13.43M
-Interest Income (Financial expense) 21.93%-1.4M39.40%-7.02M-1.89%-8.76M26.42%-3.26M26.33%-1.79M-65.57%-11.58M33.25%-8.6M41.09%-4.43M-282.16%-2.43M-67.65%-6.99M
Research and development 36.99%30.79M36.89%110.49M24.24%75.47M17.35%46.5M20.05%22.48M-2.97%80.72M2.53%60.75M-1.91%39.62M6.74%18.72M28.56%83.19M
Credit Impairment Loss -95.91%69.47K-29.64%-5.18M-128.20%-451.13K433.55%2.42M-38.93%1.7M-314.19%-3.99M260.80%1.6M45.66%-725.99K747.87%2.78M72.80%-964.14K
Asset Impairment Loss -242.54%-1.36M108.15%405.38K62.37%-828.29K21.30%-2.24M51.42%-397.78K-142.00%-4.98M-207.12%-2.2M-4,402.67%-2.85M-262.05%-818.76K20.00%-2.06M
Adjustment items of total operating cost ------------------780.11K--------------------
Other net revenue -92.47%457.3K-43.99%11.58M-98.05%471.35K-85.19%2.62M-60.39%6.08M-35.48%20.67M4.17%24.17M28.27%17.67M84.80%15.34M-17.53%32.03M
Fair value change income 242.62%2.74M-3,421.47%-57.67M-2,212.21%-12.82M-42,632.57%-6.98M-59.87%800.27K-56.51%-1.64M241.97%606.77K98.65%-16.33K123.26%1.99M-126.49%-1.05M
Invest income -589.44%-4.87M-90.51%2.22M-66.78%3.98M-78.26%2.69M-76.08%994.85K-7.13%23.39M-20.63%11.99M15.78%12.37M31.20%4.16M55.86%25.19M
Asset deal income --131.96K-76.37%34.01K59.13%22.9K261.50%47.11K-----5.92%143.93K101.76%14.39K1,547.71%13.03K189.70%13.03K2,301.50%152.99K
Other revenue 25.72%3.75M827.75%71.77M-13.14%10.56M-24.80%6.68M-58.67%2.98M-28.06%7.74M10.02%12.16M55.81%8.88M72.64%7.21M-56.72%10.75M
Operating profit 192.06%72.91M6.40%282.02M-5.99%197.56M-20.88%102.94M40.68%24.97M-8.54%265.06M-11.35%210.15M-25.01%130.1M-75.19%17.75M-8.17%289.81M
Add:Non operating Income 371.52%1.15M60.77%1.36M55.16%1.29M-57.05%536.65K-78.61%244.59K-58.20%848.83K-8.74%828.46K54.80%1.25M156.03%1.14M119.60%2.03M
Less:Non operating expense 1,557.87%4.74M-29.57%10.13M-75.43%2.11M-88.78%727.87K-73.64%286.1K31.45%14.39M3.33%8.59M162.33%6.49M-48.62%1.09M139.33%10.94M
Total profit 178.15%69.32M8.64%273.26M-2.79%196.73M-17.71%102.75M39.99%24.92M-10.46%251.52M-11.87%202.39M-27.33%124.86M-74.51%17.8M-9.96%280.9M
Less:Income tax cost 150.64%15.45M-15.97%32.97M41.23%37.03M52.58%22.8M94.75%6.17M-20.04%39.23M-10.40%26.22M-42.62%14.95M-74.65%3.17M-10.13%49.07M
Net profit 187.19%53.87M13.19%240.29M-9.35%159.7M-27.27%79.94M28.14%18.76M-8.43%212.29M-12.08%176.17M-24.60%109.92M-74.48%14.64M-9.92%231.83M
Net profit from continuing operation 187.19%53.87M13.19%240.29M-9.35%159.7M-27.27%79.94M28.14%18.76M-8.43%212.29M-12.08%176.17M-24.60%109.92M-74.48%14.64M-9.92%231.83M
Less:Minority Profit 13.94%-9.16M---40.75M---25.45M---21.24M---10.64M--------------------
Net profit of parent company owners 114.39%63.03M32.39%281.04M5.10%185.15M-7.94%101.19M100.84%29.4M-8.43%212.29M-12.08%176.17M-24.60%109.92M-74.48%14.64M-9.92%231.83M
Earning per share
Basic earning per share 113.14%0.347232.15%1.55855.10%1.03-8.20%0.56100.62%0.1629-8.42%1.1793-11.71%0.98-24.69%0.61-74.63%0.0812-9.95%1.2877
Diluted earning per share 81.97%0.347233.47%1.55858.42%1.03-5.08%0.56102.55%0.1908-4.15%1.1677-15.18%0.95-27.16%0.59-70.56%0.0942-14.21%1.2182
Other composite income 79.41%-26.69M42.61%19.67M6,584.17%73.63M2,729.92%76.35M-25,837.28%-129.63M157.35%13.79M91.48%-1.14M168.40%2.7M87.33%-499.8K-592.98%-24.05M
Other composite income of parent company owners 79.32%-21.14M3.24%14.24M6,307.64%70.49M2,663.68%74.56M-20,349.46%-102.21M157.35%13.79M91.48%-1.14M168.40%2.7M87.33%-499.8K-592.98%-24.05M
Other composite income of minority owners 79.74%-5.56M--5.43M--3.14M--1.79M---27.43M--------------------
Total composite income 124.51%27.18M14.99%259.96M33.30%233.33M38.79%156.29M-884.19%-110.88M8.80%226.08M-6.43%175.03M-20.60%112.61M-73.53%14.14M-18.16%207.79M
Total composite income of parent company owners 157.54%41.89M30.61%295.28M46.05%255.63M56.06%175.75M-614.94%-72.81M8.80%226.08M-6.43%175.03M-20.60%112.61M-73.53%14.14M-18.16%207.79M
Total composite income of minority owners 61.35%-14.72M---35.32M---22.31M---19.45M---38.07M--------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg